Davide Seruggia Team

A SAGA of instability: Without scaffold, a key driver of childhood leukemia falls apart (Vienna, 20.04.2026) – Researchers in the Seruggia group at St. Anna Children’s Cancer Research Institute (St. Anna CCRI) and the CeMM Research Center for Molecular Medicine have uncovered a new way to tackle acute myeloid leukemia (AML) cells in children: Instead of directly targeting […]

Researchers decode cancer’s genetic control panel one DNA letter at a time Scientists in Davide Seruggia’s group at St. Anna Children’s Cancer Research Institute (St. Anna CCRI), together with collaborators at the Broad Institute of MIT and Harvard, have developed CRISPR-Millipede, a new CRISPR-based method that allows researchers to study regulatory DNA sequences at single-nucleotide